TRTRIAN FUND MANAGEMENT, L.P.

Institutional investor · Portfolio as of Q1 2022

Top Holdings8 positions

Checking export access…
Activity:
11.4M$1.6B26.1%——
5 qtrssince 2021-Q1
Increased
65

INVESCO LTD

54M$1.4B23.5%$11.87+59.47%
8 qtrssince 2020-Q2
Increased
76
JHGJHGDelisted

<![CDATA[JANUS HENDERSON GROUP PLC]]>

31.9M$1.1B18.7%——
2 qtrssince 2021-Q4
Increased
73

SYSCO CORP

11.5M$939.3M15.7%$64.86+11.42%
11 qtrssince 2019-Q3
Decreased
0

WENDYS CO

25.3M$556.6M9.3%$15.21+15.00%
11 qtrssince 2019-Q3
Unchanged
0

GE AEROSPACE

4M$368.4M6.2%$62.63-11.03%
3 qtrssince 2021-Q3
Increased
63

MONDELEZ INTL INC

450,267$28.3M0.5%$46.24+19.88%
11 qtrssince 2019-Q3
Increased
37

PROCTER & GAMBLE CO

5,457$893,0000.0%$104.11+30.58%
11 qtrssince 2019-Q3
Decreased
0
$6B
AUM
8
Positions
Q1 2022
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+12%Q4'20$6.8B+25%Q1'21$8.5B+1%Q2'21$8.6B-6%Q3'21$8B-7%Q4'21$7.5B-20%Q1'22$6B
Activity profile
$ moved · Q1'22
New0%Increased41%Decreased6%Exited53%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q0%1-4Q13%1-2Y38%2Y+50%

TRIAN FUND MANAGEMENT, L.P. manages $6B across 8 positions as of Q1 2022. Top holdings: FERGL (26.1%), IVZ (23.5%), JHG (18.7%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.

Q1 2022 Summary

Exited 1, increased 5, trimmed 2. Top move: IVZ (INCREASED, conviction 76). Portfolio: $6.0B across 8 positions.

Top holdings by portfolio weight

Total AUM$6B
FERGL26.09%
IVZ23.52%
JHG18.69%
SYY15.73%
WEN9.32%
GE6.17%
MDLZ0.47%
PG0.01%
CMCSA0.00%

Portfolio allocation by GICS sector

Sectors5
Financial Services42.21%
Unknown26.09%
Consumer Defensive16.21%
Consumer Cyclical9.32%
Industrials6.17%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services, Unknown, Consumer Defensive
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L80
Conviction44
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
WENWENWENDYS CO
Q2 2025 → Q2 2026+44,751 shares-$192.5M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used